As part of the exploratory analysis, we investigated whether PALB2-associated breast cancers would differ from non-BRCA1/2/PALB2-associated breast cancers in regard to the frequencies of genomic features indicative of HRD. This evidence concerns the gene BRCA1 and breast carcinoma.